P. Dong

发表

Emerging Therapeutic Biomarkers in Endometrial Cancer

P. Dong, M. Kaneuchi, Yosuke Konno, 2013, BioMed research international.

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers

P. Dong, Yosuke Konno, H. Watari, 2020, Cancers.

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation

P. Dong, H. Watari, J. Yue, 2017, Journal of Experimental & Clinical Cancer Research.

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

P. Dong, H. Watari, J. Yue, 2018, Front. Oncol..

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143

P. Dong, Yosuke Konno, H. Watari, 2022, Frontiers in Oncology.

iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling

P. Dong, H. Watari, J. Yue, 2017, Journal of experimental & clinical cancer research : CR.

New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system

P. Dong, M. Kaneuchi, H. Watari, 2012, Journal of surgical oncology.

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges

P. Dong, H. Watari, J. Yue, 2019, Cancers.

HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use

P. Dong, H. Watari, N. Sakuragi, 2016, Journal of medical screening.

Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women

P. Dong, H. Watari, N. Sakuragi, 2018, Cancer science.

Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications

P. Dong, Yosuke Konno, H. Watari, 2021, Frontiers in Cell and Developmental Biology.

Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

P. Dong, H. Watari, N. Sakuragi, 2014, Molecular Cancer.

FAK PROTAC Inhibits Ovarian Tumor Growth and Metastasis by Disrupting Kinase Dependent and Independent Pathways

P. Dong, H. Watari, L. Pfeffer, 2022, Frontiers in Oncology.

A review on the role of cyclin dependent kinases in cancers

P. Dong, N. Gassler, M. Taheri, 2022, Cancer Cell International.

LncRNAs: Novel Biomarkers for Pancreatic Cancer

P. Dong, M. Taheri, S. Ghafouri-Fard, 2021, Biomolecules.

Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis

P. Dong, N. Sakuragi, Qi Zhang, 2017, Scientific Reports.

Editorial: Non-Coding RNAs in Gastrointestinal and Gynecological Cancers: New Insights Into the Mechanisms of Cancer Therapeutic Resistance

P. Dong, J. Yue, Feng Wang, 2022, Frontiers in Cell and Developmental Biology.

A self-pumping dressing with in situ modification of non-woven fabric for promoting diabetic wound healing

P. Dong, Guanghui Gao, Xi Zhang, 2022, Chemical Engineering Journal.

PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3

P. Dong, Yosuke Konno, H. Watari, 2020, Frontiers in Cell and Developmental Biology.

Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells

P. Dong, H. Watari, E. Chaum, 2017, Journal of Cancer.

Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors

P. Dong, H. Watari, J. Yue, 2018, Front. Genet..

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

P. Dong, H. Watari, J. Yue, 2018, Front. Oncol..

MicroRNA‐106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines

P. Dong, M. Kaneuchi, H. Watari, 2014, Molecular carcinogenesis.

MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation

P. Dong, Yosuke Konno, H. Watari, 2019, Cancers.

Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer

P. Dong, H. Watari, N. Sakuragi, 2018, Oncogene.

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

Wei Li, Xia Li, P. Dong, 2018, Journal of Experimental & Clinical Cancer Research.

Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells

P. Dong, H. Watari, Guannan Zhao, 2017, Oncotarget.

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

P. Dong, M. Kaneuchi, H. Watari, 2011, Molecular Cancer.

p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells

P. Dong, N. Sakuragi, M. Tada, 2007, Clinical & Experimental Metastasis.

Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

P. Dong, M. Kaneuchi, H. Watari, 2012, Oncogene.

Molecular-targeted therapies and precision medicine for endometrial cancer.

P. Dong, H. Watari, K. Ihira, 2018, Japanese journal of clinical oncology.

MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways

P. Dong, Y. Sun, K. Mitchelson, 2012, Oncogene.

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

P. Dong, Yosuke Konno, H. Watari, 2014, Oncotarget.

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

P. Dong, H. Watari, N. Sakuragi, 2015, Oncotarget.

PIWI-Interacting RNAs (piRNAs): Promising Applications as Emerging Biomarkers for Digestive System Cancer

P. Dong, Q. Qi, Yixuan Wu, 2022, Frontiers in Molecular Biosciences.

Prognostic significance of miR-194 in endometrial cancer

P. Dong, N. Sakuragi, J. Ju, 2013, Biomarker Research.

Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor

P. Dong, H. Watari, L. Pfeffer, 2019, Molecular Cancer Therapeutics.

Lentiviral CRISPR / Cas 9 nickase vector mediated BIRC 5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells

P. Dong, H. Watari, Guannan Zhao, 2019 .

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer

P. Dong, Yosuke Konno, H. Watari, 2014, Journal of Translational Medicine.

Genetic model of endometrial carcinogenesis

P. Dong, H. Watari, N. Sakuragi, 2014 .

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway

P. Dong, Yosuke Konno, H. Watari, 2021, Journal of Experimental & Clinical Cancer Research.

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells

P. Dong, Yosuke Konno, H. Watari, 2016, Journal of experimental & clinical cancer research : CR.

Molecular targets and targeted therapy

P. Dong, Peixin Dong, 2014 .

Editorial: Non-coding RNAs in gastrointestinal and gynecological cancers: New insights into the mechanisms of cancer therapeutic resistance, volume II

P. Dong, J. Yue, L. Chang, 2023, Frontiers in cell and developmental biology.

Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

P. Dong, M. Kaneuchi, H. Watari, 2012, Oncogene.

Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124

P. Dong, Yosuke Konno, H. Watari, 2016, Scientific Reports.

Distribution of Lymph Node Metastasis Sites in Endometrial Cancer Undergoing Systematic Pelvic and Para-Aortic Lymphadenectomy: A Proposal of Optimal Lymphadenectomy for Future Clinical Trials

P. Dong, H. Watari, S. Sudo, 2014, Annals of Surgical Oncology.

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression

P. Dong, H. Watari, N. Sakuragi, 2016, Oncotarget.

MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1

P. Dong, Yosuke Konno, H. Watari, 2020, Cells.

EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway

P. Dong, H. Watari, L. Pfeffer, 2021, Cell & bioscience.

KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells.

Tao Zhang, P. Dong, H. Watari, 2017, Biochemical and biophysical research communications.

Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells

Peng Zhang, P. Dong, H. Watari, 2018, Journal of Cancer.

Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells.

Tao Zhang, P. Dong, H. Watari, 2018, Oncology letters.

Challenges in breast and cervical cancer control in Japan.

P. Dong, N. Sakuragi, A. Tamakoshi, 2016, The Lancet. Oncology.

Zinc regulates primary ovarian tumor growth and metastasis through the epithelial to mesenchymal transition.

P. Dong, H. Watari, L. Pfeffer, 2020, Free radical biology & medicine.

miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation

P. Dong, H. Watari, J. Yue, 2018, Oncotarget.

EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis

P. Dong, Yosuke Konno, H. Watari, 2017, Oncotarget.

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer

P. Dong, Yosuke Konno, H. Watari, 2023, Journal of Translational Medicine.

Emerging functions and clinical applications of exosomal microRNAs in diseases

P. Dong, M. Taheri, S. Ghafouri-Fard, 2023, Non-coding RNA research.

Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin

P. Dong, Q. Qi, S. Ju, 2022, Journal of experimental & clinical cancer research : CR.

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis

P. Dong, 2013 .

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

P. Dong, Yosuke Konno, H. Watari, 2019, Journal of Experimental & Clinical Cancer Research.

Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway

P. Dong, H. Watari, Guannan Zhao, 2022, Frontiers in Cell and Developmental Biology.

Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.

P. Dong, M. Kaneuchi, Yosuke Konno, 2014, Carcinogenesis.

L1CAM Predicts Adverse Outcomes in Patients with Endometrial Cancer Undergoing Full Lymphadenectomy and Adjuvant Chemotherapy

P. Dong, Yosuke Konno, H. Watari, 2019, Annals of Surgical Oncology.

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation

P. Dong, H. Watari, J. Yue, 2017, Journal of experimental & clinical cancer research : CR.

A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways

P. Dong, H. Watari, Guannan Zhao, 2021, Journal of Cancer.

Lentiviral CRISPR / Cas 9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells

P. Dong, H. Watari, E. Chaum, 2017 .

Lentiviral vector mediated-ASAP 1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells

Tao Zhang, P. Dong, H. Watari, 2018 .

The significance of N6-methyladenosine-modified non-coding RNAs in different disorders.

P. Dong, M. Taheri, S. Ghafouri-Fard, 2023, European journal of pharmacology.

Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey.

P. Dong, Lixia Huang, Shao-li Li, 2023, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.